by Patrick Wingrove
(Reuters) – Pharmaceutical company Eli Lilly announced on Wednesday a partnership with e-commerce giant Amazon to deliver medicines through its direct-to-consumer sales service, LillyDirect.
Eli Lilly launched the platform in January to allow patients to get their medications, including popular obesity treatment Zepbound, delivered directly through its online pharmacy Truepill.
Medications sent to Lilly Direct Pharmacy Solutions will be delivered directly by Amazon Pharmacy or Truepill, depending on the patient’s health coverage.
Read also…
Lilly Vice President of Healthcare Services Frank Cunningham said he plans to split orders between the two companies. He added that Lilly was “very happy” with the number of orders placed through LillyDirect without disclosing figures.
The website has generated great interest since its launch and the drugmaker “looks forward to continuing to enhance LillyDirect with additional medicines, partners and service providers in the near future,” a spokesperson for the group said. in an email.
The group is also considering partnering with retail pharmacies to offer a collection solution to LillyDirect customers.
LillyDirect was launched as demand for the treatment of obesity exploded last year in the wake of Zepbound and Wegovy developed by Novo Nordisk.
The market for obesity drugs could reach at least $100 billion by the end of the decade.
(French version Zhifan Liu, edited by Kate Entringer)
©2024 Thomson Reuters, all rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. “Reuters” and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.